Location: New York, NY
CIK: 0001351351 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value: $94.8M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | KARUNA THERAPEUTICS INC | 126,206 | $39.95M | 42.1% | $316.51 | — | COM | 48576A100 |
| — | UNITED STATES STL CORP NEW | 255,929 | $12.45M | 13.1% | $48.65 | — | COM | 912909108 |
| — | CEREVEL THERAPEUTICS HLDNG I | 232,705 | $9.867M | 10.4% | $42.40 | — | COM | 15678U128 |
| — | SPLUNK INC | 59,650 | $9.088M | 9.6% | $152.35 | — | COM | 848637104 |
| — | ENDEAVOR GROUP HLDGS INC | 376,468 | $8.934M | 9.4% | $23.73 | — | CL A COM | 29260Y109 |
| — | IMMUNOGEN INC | 221,622 | $6.571M | 6.9% | $29.65 | — | COM | 45253H101 |
| KVUE | KENVUE INC | 142,400 | $3.066M | 3.2% | $21.04 | -12.5% | COM | 49177J102 |
| — | PIONEER NAT RES CO | 11,500 | $2.586M | 2.7% | $224.88 | — | COM | 723787107 |
| KVUE | KENVUE INC | 86,300 | $1.858M | 2.0% | $21.04 | -12.5% | Call | 49177J102 |
| — | KARUNA THERAPEUTICS INC | 1,100 | $348K | 0.4% | $316.51 | — | Call | 48576A100 |
| — | UNITED STATES STL CORP NEW | 1,800 | $87,570 | 0.1% | $48.65 | — | Call | 912909108 |